MITCHELL BLISS: Open Payments
NPI 1760144687 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 8 companies in 2025. Trend: 2023 $215 · 2024 $229 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, PREVNAR 20, EVENITY, Ozempic, QULIPTA, Dexcom G6 Transmitter, MOUNJARO, REXULTI.
Industry payments across ID — which companies pay providers there.
